99% Savings - Buy Just @1 Rs X
Bortenat 3.5 Injection is a prescription medicine that is available as a Injection. Multiple Myeloma are some of its major therapeutic uses. Other than this, Bortenat 3.5 Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Bortenat 3.5 Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Bortenat 3.5 Injection can also lead to other problems, which have been listed below. Such side effects of Bortenat 3.5 Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Bortenat 3.5 Injection's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Bortenat 3.5 Injection's effects on the liver, heart and kidney are discussed below in the Bortenat 3.5 Injection related warnings section.
Individuals suffering from medical conditions like Gastrointestinal Bleeding must refrain from the use of Bortenat 3.5 Injection since this can cause severe adverse effects. The section on Bortenat 3.5 Injection contraindications lists all such conditions.
Drug interactions for Bortenat 3.5 Injection have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Bortenat 3.5 Injection is considered not safe while driving, and is not addictive.
Bortenat 3.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Bortenat 3.5 Injection safe for pregnant women?
Bortenat shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Bortenat 3.5 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Bortenat. It should only be taken after medical advice.
What is the effect of Bortenat 3.5 Injection on the Kidneys?
Using Bortenat does not have any harmful effects on kidneys.
What is the effect of Bortenat 3.5 Injection on the Liver?
Bortenat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Bortenat 3.5 Injection on the Heart?
Bortenat may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Bortenat 3.5 Injection unless your doctor advises you to do so -
Is this Bortenat 3.5 Injection habit forming or addictive?
Bortenat 3.5 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Bortenat 3.5 Injection. So it is best to avoid driving.
Is it safe?
Bortenat 3.5 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Bortenat 3.5 Injection cannot treat any kind of mental disorder.
Interaction between Food and Bortenat 3.5 Injection
Taking Bortenat 3.5 Injection with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Bortenat 3.5 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Bortenat 3.5 Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 234-235
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Velcade® (bortezomib)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bortezomib Aft (Bortezomib)